Fortress Biotech, Inc. (NASDAQ:FBIOP) Sees Large Drop in Short Interest

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the target of a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 500 shares, a decrease of 78.3% from the January 31st total of 2,300 shares. Based on an average daily trading volume, of 11,700 shares, the short-interest ratio is presently 0.0 days.

Fortress Biotech Price Performance

Shares of Fortress Biotech stock opened at $5.82 on Friday. The firm has a fifty day moving average price of $6.60 and a two-hundred day moving average price of $6.12. Fortress Biotech has a fifty-two week low of $4.86 and a fifty-two week high of $18.00.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.